Search

Your search keyword '"Vermaat, Joost S.P"' showing total 34 results

Search Constraints

Start Over You searched for: Author "Vermaat, Joost S.P" Remove constraint Author: "Vermaat, Joost S.P" Search Limiters Full Text Remove constraint Search Limiters: Full Text Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
34 results on '"Vermaat, Joost S.P"'

Search Results

1. Treatment strategies and outcome in relapsed peripheral T-cell lymphoma: results from the Netherlands Cancer Registry

2. Detection of Second Primary Lymphoma in Late Diffuse Large B-cell Lymphoma Recurrences

3. Sinonasal DLBCL: molecular profiling identifies subtypes with distinctive prognoses and targetable genetic features

4. Impact of etoposide and ASCT on survival among patients aged

5. Frequent mutated B2M, EZH2, IRF8, and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype

6. Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma: a Dutch population-based study

7. Outcome of combined modality treatment in first-line for stage I(E) peripheral T-cell lymphoma; a nationwide population-based cohort study from the Netherlands

8. P1159: INFERIOR OUTCOME OF FRAIL AND UNFIT PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH ATTENUATED R-CHOP

9. P1128: EVALUATION OF STANDARD OF CARE IN SECOND-LINE FOR PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN THE PRE-CAR-T ERA: A DUTCH POPULATION-BASED STUDY

10. Molecular Diagnostics for TP53 Is Recommended in B-Cell Lymphomas

11. Outcome of Transformed Marginal Zone Lymphoma: A Population Based Study

12. Prophylactic Donor Lymphocyte Infusion in Patients after Allogeneic Stem Cell Transplantation with Post-Transplant Cyclophosphamide Is Associated with Low Relapse Risk and Excellent Survival in Patients below 65 Years with Acute Myeloid Leukemia and High-Risk Myelodysplasia

13. Polyostotic DLBCL Is Characterized By a NF-Κb Pathway Affecting Molecular Profile and Superior Survival

14. Antigen-Independent, Autonomous B-Cell Receptor Signaling in Diffuse Large B-Cell Lymphoma

15. Autonomous BCR Signaling and Genetic Aberrations in CLL-Phenotype Monoclonal B Lymphocytosis in Siblings of CLL Patients

16. Genomic Landscaping of Post-Transplant Lymphoproliferative Disorders Using Circulating Tumor DNA

17. Consolidation Improves Survival in Primary Central Nervous System Lymphoma without Preference for Type of High-Dose Methotrexate-Based Induction Treatment Regimen

18. Special Anatomical Subtypes of Diffuse Large B-Cell Lymphoma Have Distinct Tumor Microenvironments

19. Harnessing Cell-Free DNA Biological Features for Early Treatment Response Prediction in High Grade B-Cell Lymphoma

20. A Propensity Score-Adjusted Comparison of Lenalidomide + R-CHOP Versus R-CHOP for MYC-Rearranged DLBCL Patients

21. Subcutaneous Epcoritamab in Combination with Rituximab + Lenalidomide (R2) for First-Line Treatment of Follicular Lymphoma: Initial Results from Phase 1/2 Trial

22. Effects of HLA Mismatches on Cytokine Release Syndrome and Associated Non-Relapse Mortality in Allogeneic Stem Cell Transplantation with Post-Transplant Cyclophosphamide

23. Low Mutational Burden of Extra Nodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue in Patients with Primary Sjogren's Syndrome

24. First-Line Treatment and Survival of Stage I(E) Peripheral T-Cell Lymphoma in the Netherlands; A Nationwide Population-Based Cohort Study

25. Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus phaselenalidomide:II HOVON trial results of a multicenter

26. High frequency of inactivating tetraspanin CD37 mutations in diffuse large B-cell lymphoma at immune-privileged sites

29. High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma

31. Frequent mutated B2M, EZH2, IRF8, and TNFRSF14in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype

33. High frequency of inactivating tetraspanin CD37mutations in diffuse large B-cell lymphoma at immune-privileged sites

34. High prevalence of MYD88and CD79Bmutations in intravascular large B-cell lymphoma

Catalog

Books, media, physical & digital resources